Trends in net survival from head and neck cancer in six European Latin countries: Results from the SUDCAN population-based study

A.-V. Guizard, Z. Uhry, D. De Raucourt, G. Mazzoleni, M.-J. Sánchez, K. Ligier, Roberta De Angelis, Massimiliano Caldora, Eugenio Carrani, Silvia Giovanna Luisa Francisci, Sandra Mallone, Daniela Pierannunzio, Paolo Roazzi, Silvia Rossi, Mariano Santaquilani, andrea tavilla

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of the SUDCAN collaborative study was to compare the trends in 1- and 5-year net survival and the trends in the dynamics of the excess mortality rates in head and neck cancers between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. There were significant differences between countries in 5-year age-standardized net survivals over the 2000-2004 period, ranging from 33 to 34% in France and Portugal from 42 to 44% in Switzerland and Italy, respectively. The age-standardized net survival improved considerably from 1992 to 2004 in Italy, Spain and Switzerland, but not in France because of lack of improvement in the elderly. The increase in net survival was linked to a decrease in the excess mortality rate up to 3-4 years after diagnosis. The net survival from head and neck cancers improved over the study period, but significant differences were still observed in 2004. Differences in sex ratio and anatomical distribution contributed only partially towards these disparities. Differences in stage at diagnosis, time to treatment and/or proportion of human papillomavirus-related cases are also probably involved in the survival disparities observed. Overall, the prognosis of these tumours remains poor. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)S16-S23
JournalEuropean Journal of Cancer Prevention
Volume26
Issue numberSuppl 1
DOIs
Publication statusPublished - 2017

Fingerprint

Head and Neck Neoplasms
Survival
Switzerland
Italy
France
Portugal
Population
Spain
Mortality
Belgium
Sex Ratio
Demography
Databases
Health
Neoplasms

Keywords

  • Cancer registries
  • Europe
  • Excess mortality rate
  • Head and neck cancer
  • Net survival
  • Trend analysis
  • adolescent
  • adult
  • Article
  • Belgium
  • cancer survival
  • female
  • France
  • head and neck cancer
  • human
  • hypopharynx tumor
  • Italy
  • male
  • mortality rate
  • Portugal
  • priority journal
  • Spain
  • survival rate
  • Switzerland
  • aged
  • epidemiology
  • factual database
  • follow up
  • head and neck tumor
  • health survey
  • middle aged
  • mortality
  • procedures
  • trends
  • young adult
  • Adolescent
  • Adult
  • Aged
  • Databases, Factual
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms
  • Humans
  • Male
  • Middle Aged
  • Population Surveillance
  • Survival Rate
  • Young Adult

Cite this

@article{9849b9cfc8004cd2a1f83d1362d47e92,
title = "Trends in net survival from head and neck cancer in six European Latin countries: Results from the SUDCAN population-based study",
abstract = "The aim of the SUDCAN collaborative study was to compare the trends in 1- and 5-year net survival and the trends in the dynamics of the excess mortality rates in head and neck cancers between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. There were significant differences between countries in 5-year age-standardized net survivals over the 2000-2004 period, ranging from 33 to 34{\%} in France and Portugal from 42 to 44{\%} in Switzerland and Italy, respectively. The age-standardized net survival improved considerably from 1992 to 2004 in Italy, Spain and Switzerland, but not in France because of lack of improvement in the elderly. The increase in net survival was linked to a decrease in the excess mortality rate up to 3-4 years after diagnosis. The net survival from head and neck cancers improved over the study period, but significant differences were still observed in 2004. Differences in sex ratio and anatomical distribution contributed only partially towards these disparities. Differences in stage at diagnosis, time to treatment and/or proportion of human papillomavirus-related cases are also probably involved in the survival disparities observed. Overall, the prognosis of these tumours remains poor. Copyright {\circledC} 2017 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "Cancer registries, Europe, Excess mortality rate, Head and neck cancer, Net survival, Trend analysis, adolescent, adult, Article, Belgium, cancer survival, female, France, head and neck cancer, human, hypopharynx tumor, Italy, male, mortality rate, Portugal, priority journal, Spain, survival rate, Switzerland, aged, epidemiology, factual database, follow up, head and neck tumor, health survey, middle aged, mortality, procedures, trends, young adult, Adolescent, Adult, Aged, Databases, Factual, Female, Follow-Up Studies, Head and Neck Neoplasms, Humans, Male, Middle Aged, Population Surveillance, Survival Rate, Young Adult",
author = "A.-V. Guizard and Z. Uhry and {De Raucourt}, D. and G. Mazzoleni and M.-J. S{\'a}nchez and K. Ligier and {De Angelis}, Roberta and Massimiliano Caldora and Eugenio Carrani and Francisci, {Silvia Giovanna Luisa} and Sandra Mallone and Daniela Pierannunzio and Paolo Roazzi and Silvia Rossi and Mariano Santaquilani and andrea tavilla",
note = "Cited By :3 Export Date: 11 April 2018 CODEN: EJUPE Correspondence Address: Guizard, A.-V.; Department of Head and Neck Surgery, Fran{\cc}ois Baclesse Cancer Center, Avenue du General Harris BP 5026, France; email: av.guizard@baclesse.unicancer.fr Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: Ligue Contre le Cancer Funding details: EC, European Commission Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Belcher, R., Hayes, K., Fedewa, S., Chen, A.Y., Current treatment of head and neck squamous cell cancer (2014) J Surg Oncol, 110, pp. 551-574; Chen, Z., King, W., Pearcey, R., Kerba, M., Mackillop, W.J., The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature (2008) Radiother Oncol, 87, pp. 3-16; Crocetti, E., Bossard, N., Uhry, Z., Roche, L., Rossi, S., Capocaccia, R., Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material (2016) Eur J Cancer Prev, 25, pp. S3-S8; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., (2013) GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 11, , http://globocan.iarc.fr, Lyon, France: International Agency for Research on Cancer. [Accessed 12 February 2015]; Marur, S., D'Souza, G., Westra, W.H., Forastiere, A.A., HPV-associated head and neck cancer: A virus-related cancer epidemic (2010) Lancet Oncol, 11, pp. 781-789; Perme, M.P., Stare, J., Esteve, J., On estimation in relative survival (2012) Biometrics, 68, pp. 113-120; Pignon, J.P., Le Ma{\^i}tre, A., Maillard, E., Bourhis, J., Meta-analysis of chemotherapy in head and neck cancer (MACHNC): An update on 93 randomised trials and 17 346 patients (2009) Radiother Oncol, 92, pp. 4-14; Pulte, D., Brenner, H., Changes in survival in head and neck cancers in the late 20th and early 21st century: A period analysis (2010) Oncologist, 15, pp. 994-1001; Stefanuto, P., Doucet, J.C., Robertson, C., Delays in treatment of oral cancer: A review of the current literature (2014) Oral Surg Oral Med Oral Pathol Oral Radiol, 117, pp. 424-429; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15; Van Harten, M.C., Hoebers, F.J., Kross, K.W., Van Werkhoven, E.D., Van Den-Brekel, M.W., Van Dijk, B.A., Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival (2015) Oral Oncol, 51, pp. 272-278; Zigon, G., Berrino, F., Gatta, G., S{\'a}nchez, M.J., Van Dijk, B., Van Eycken, E., Francisci, S., Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: A population-based study (2011) Ann Oncol, 22, pp. 165-174",
year = "2017",
doi = "10.1097/CEJ.0000000000000296",
language = "English",
volume = "26",
pages = "S16--S23",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "Suppl 1",

}

TY - JOUR

T1 - Trends in net survival from head and neck cancer in six European Latin countries: Results from the SUDCAN population-based study

AU - Guizard, A.-V.

AU - Uhry, Z.

AU - De Raucourt, D.

AU - Mazzoleni, G.

AU - Sánchez, M.-J.

AU - Ligier, K.

AU - De Angelis, Roberta

AU - Caldora, Massimiliano

AU - Carrani, Eugenio

AU - Francisci, Silvia Giovanna Luisa

AU - Mallone, Sandra

AU - Pierannunzio, Daniela

AU - Roazzi, Paolo

AU - Rossi, Silvia

AU - Santaquilani, Mariano

AU - tavilla, andrea

N1 - Cited By :3 Export Date: 11 April 2018 CODEN: EJUPE Correspondence Address: Guizard, A.-V.; Department of Head and Neck Surgery, François Baclesse Cancer Center, Avenue du General Harris BP 5026, France; email: av.guizard@baclesse.unicancer.fr Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: Ligue Contre le Cancer Funding details: EC, European Commission Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Belcher, R., Hayes, K., Fedewa, S., Chen, A.Y., Current treatment of head and neck squamous cell cancer (2014) J Surg Oncol, 110, pp. 551-574; Chen, Z., King, W., Pearcey, R., Kerba, M., Mackillop, W.J., The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature (2008) Radiother Oncol, 87, pp. 3-16; Crocetti, E., Bossard, N., Uhry, Z., Roche, L., Rossi, S., Capocaccia, R., Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material (2016) Eur J Cancer Prev, 25, pp. S3-S8; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., (2013) GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 11, , http://globocan.iarc.fr, Lyon, France: International Agency for Research on Cancer. [Accessed 12 February 2015]; Marur, S., D'Souza, G., Westra, W.H., Forastiere, A.A., HPV-associated head and neck cancer: A virus-related cancer epidemic (2010) Lancet Oncol, 11, pp. 781-789; Perme, M.P., Stare, J., Esteve, J., On estimation in relative survival (2012) Biometrics, 68, pp. 113-120; Pignon, J.P., Le Maître, A., Maillard, E., Bourhis, J., Meta-analysis of chemotherapy in head and neck cancer (MACHNC): An update on 93 randomised trials and 17 346 patients (2009) Radiother Oncol, 92, pp. 4-14; Pulte, D., Brenner, H., Changes in survival in head and neck cancers in the late 20th and early 21st century: A period analysis (2010) Oncologist, 15, pp. 994-1001; Stefanuto, P., Doucet, J.C., Robertson, C., Delays in treatment of oral cancer: A review of the current literature (2014) Oral Surg Oral Med Oral Pathol Oral Radiol, 117, pp. 424-429; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15; Van Harten, M.C., Hoebers, F.J., Kross, K.W., Van Werkhoven, E.D., Van Den-Brekel, M.W., Van Dijk, B.A., Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival (2015) Oral Oncol, 51, pp. 272-278; Zigon, G., Berrino, F., Gatta, G., Sánchez, M.J., Van Dijk, B., Van Eycken, E., Francisci, S., Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: A population-based study (2011) Ann Oncol, 22, pp. 165-174

PY - 2017

Y1 - 2017

N2 - The aim of the SUDCAN collaborative study was to compare the trends in 1- and 5-year net survival and the trends in the dynamics of the excess mortality rates in head and neck cancers between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. There were significant differences between countries in 5-year age-standardized net survivals over the 2000-2004 period, ranging from 33 to 34% in France and Portugal from 42 to 44% in Switzerland and Italy, respectively. The age-standardized net survival improved considerably from 1992 to 2004 in Italy, Spain and Switzerland, but not in France because of lack of improvement in the elderly. The increase in net survival was linked to a decrease in the excess mortality rate up to 3-4 years after diagnosis. The net survival from head and neck cancers improved over the study period, but significant differences were still observed in 2004. Differences in sex ratio and anatomical distribution contributed only partially towards these disparities. Differences in stage at diagnosis, time to treatment and/or proportion of human papillomavirus-related cases are also probably involved in the survival disparities observed. Overall, the prognosis of these tumours remains poor. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

AB - The aim of the SUDCAN collaborative study was to compare the trends in 1- and 5-year net survival and the trends in the dynamics of the excess mortality rates in head and neck cancers between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. There were significant differences between countries in 5-year age-standardized net survivals over the 2000-2004 period, ranging from 33 to 34% in France and Portugal from 42 to 44% in Switzerland and Italy, respectively. The age-standardized net survival improved considerably from 1992 to 2004 in Italy, Spain and Switzerland, but not in France because of lack of improvement in the elderly. The increase in net survival was linked to a decrease in the excess mortality rate up to 3-4 years after diagnosis. The net survival from head and neck cancers improved over the study period, but significant differences were still observed in 2004. Differences in sex ratio and anatomical distribution contributed only partially towards these disparities. Differences in stage at diagnosis, time to treatment and/or proportion of human papillomavirus-related cases are also probably involved in the survival disparities observed. Overall, the prognosis of these tumours remains poor. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

KW - Cancer registries

KW - Europe

KW - Excess mortality rate

KW - Head and neck cancer

KW - Net survival

KW - Trend analysis

KW - adolescent

KW - adult

KW - Article

KW - Belgium

KW - cancer survival

KW - female

KW - France

KW - head and neck cancer

KW - human

KW - hypopharynx tumor

KW - Italy

KW - male

KW - mortality rate

KW - Portugal

KW - priority journal

KW - Spain

KW - survival rate

KW - Switzerland

KW - aged

KW - epidemiology

KW - factual database

KW - follow up

KW - head and neck tumor

KW - health survey

KW - middle aged

KW - mortality

KW - procedures

KW - trends

KW - young adult

KW - Adolescent

KW - Adult

KW - Aged

KW - Databases, Factual

KW - Female

KW - Follow-Up Studies

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Population Surveillance

KW - Survival Rate

KW - Young Adult

U2 - 10.1097/CEJ.0000000000000296

DO - 10.1097/CEJ.0000000000000296

M3 - Article

VL - 26

SP - S16-S23

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - Suppl 1

ER -